Medical Associate Director - Rare Disease Clinical Leader in Cambridge

Medical Associate Director - Rare Disease Clinical Leader in Cambridge

Cambridge Full-Time 85500 - 104500 $ / year (est.) On-site
C

At a Glance

  • Tasks: Lead clinical strategy and trial delivery for late-stage rare disease programmes.
  • Company: Cycle Pharmaceuticals, a pioneering company in rare disease research.
  • Benefits: Competitive salary, health benefits, and opportunities for professional growth.
  • Other info: Collaborative global environment with a focus on impactful research.
  • Why this job: Make a real difference in patients' lives by shaping innovative clinical trials.
  • Qualifications: Experience in clinical development and strong leadership skills.

The predicted salary is between 85500 - 104500 $ per year.

Cycle Pharmaceuticals in Cambridge is seeking a Medical Associate Director - Clinical Development to provide medical leadership across late-stage programmes, shaping clinical strategy and trial delivery for Phase 2 and 3 studies in rare diseases.

You will act as sponsor medical lead, integrating clinical pharmacology and translational science, and drive regulatory submissions while collaborating with cross-functional teams across global trials.

Medical Associate Director - Rare Disease Clinical Leader in Cambridge employer: Cycle Pharmaceuticals

Cycle Pharmaceuticals is dedicated to making a meaningful impact in the field of rare diseases, with a strong focus on oncology, hematology, neurology, and rare metabolic conditions. The company fosters a collaborative work environment that emphasizes professional growth and the importance of every patient. Employees benefit from hybrid working arrangements and the opportunity to contribute to innovative pharmaceutical development.

C

Contact Details:

Cycle Pharmaceuticals Recruitment Team

We think you need these skills to ace Medical Associate Director - Rare Disease Clinical Leader in Cambridge

Medical Leadership
Clinical Strategy Development
Trial Delivery Management
Phase 2 and 3 Study Expertise
Clinical Pharmacology Knowledge
Translational Science Integration
Regulatory Submission Experience